HIV infection, in combination with other antiretroviral
drugs (initiated by a specialist)
▶BY MOUTH
▶Adult: 800/150 mg once daily, dosage should not be
altered or therapy discontinued without instruction
from the healthcare provider
DOSE EQUIVALENCE AND CONVERSION
▶Dose expressed as x/y mg of darunavir/cobicistat.
PDF page 716
Treatment-experienced patients
with 1 or more darunavir resistance-associated mutations,
plasma HIV-RNA concentration of 100 000 copies/mL or
greater, or CD4 count less than 100 cells 6106/litre
PDF page 716
Elderly
PDF page 716
Scottish Medicines Consortium (SMC) decisions
SMC No. 1081/15
The Scottish Medicines Consortium has advised (August
2015) that darunavir with cobicistat (Rezolsta ®) is accepted
for use within NHS Scotland for the treatment of human
immunodeficiency virus-1 (HIV-1) infection in adults, in
combination with other antiretrovirals. Genotypic testing
should guide its use.
PDF page 717